166 related articles for article (PubMed ID: 24936676)
1. Immunohistochemical expression of MCM2 in nonmelanoma epithelial skin cancers.
Abdou AG; Elwahed MG; Serag El-Dien MM; Eldien DS
Am J Dermatopathol; 2014 Dec; 36(12):959-64. PubMed ID: 24936676
[TBL] [Abstract][Full Text] [Related]
2. Expression of minichromosome maintenance 5 protein in proliferative and malignant skin diseases.
Liu H; Takeuchi S; Moroi Y; Lin N; Urabe K; Kokuba H; Imafuku S; Dainichi T; Uchi H; Furue M; Tu Y
Int J Dermatol; 2007 Nov; 46(11):1171-6. PubMed ID: 17988337
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of sperm-associated antigen 9 in nonmelanoma skin cancer.
Seleit I; Bakry OA; Samaka RM; Malak MA
Am J Dermatopathol; 2015 Jan; 37(1):38-45. PubMed ID: 25033008
[TBL] [Abstract][Full Text] [Related]
5. p53 protein expression and cell proliferation in non-neoplastic and neoplastic proliferative skin diseases.
Batinac T; Zamolo G; Jonjić N; Gruber F; Petrovecki M
Tumori; 2004; 90(1):120-7. PubMed ID: 15143984
[TBL] [Abstract][Full Text] [Related]
6. Expression of matrix metalloproteinase-13 and Ki-67 in nonmelanoma skin cancer in xeroderma pigmentosum and non-xeroderma pigmentosum.
El-Hawary AK; Yassin E; Khater A; Abdelgaber S
Am J Dermatopathol; 2013 Feb; 35(1):45-9. PubMed ID: 22722466
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of ezrin in cutaneous basal and squamous cell carcinomas.
Abdou AG; Maraee AH; El-Sayed EM; Elnaidany NF
Ann Diagn Pathol; 2011 Dec; 15(6):394-401. PubMed ID: 21849257
[TBL] [Abstract][Full Text] [Related]
8. [Effect of STAT3 phosphorylation and p53 expression on human epidermal non melanoma cutaneous tumors].
Cai SQ; Chen LR; Wang HJ; Yao LF; Zheng M
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2004 Jul; 33(4):331-4. PubMed ID: 15269985
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of CD10 and Bcl2 expression in distinguishing cutaneous basal cell carcinoma from squamous cell carcinoma and seborrheic keratosis.
Gaballah MA; Ahmed RA
Pathol Res Pract; 2015 Dec; 211(12):931-8. PubMed ID: 26573127
[TBL] [Abstract][Full Text] [Related]
10. The expression of p53 and COX-2 in basal cell carcinoma, squamous cell carcinoma and actinic keratosis cases.
Karagece Yalçin U; Seçkın S
Turk Patoloji Derg; 2012; 28(2):119-27. PubMed ID: 22627629
[TBL] [Abstract][Full Text] [Related]
11. Significance of PC cell-derived growth factor and cyclin D1 expression in cutaneous squamous cell carcinoma.
Huang K; Huang C; Shan K; Chen J; Li H
Clin Exp Dermatol; 2012 Jun; 37(4):411-7. PubMed ID: 22420613
[TBL] [Abstract][Full Text] [Related]
12. [The prognostic molecular factors in precancerous lesions and nonmelanotic skin carcinoma].
Mihailovici MS; Teleman S; Ungureanu C
Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):494-501. PubMed ID: 14756051
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical assessment of endothelin-1 axis in psoriasis, basal cell carcinoma and squamous cell carcinoma.
Salem SA; Gamal Aly D; Salah Youssef N; Moneim El-Shaer MA
G Ital Dermatol Venereol; 2015 Jun; 150(3):283-91. PubMed ID: 25946671
[TBL] [Abstract][Full Text] [Related]
14. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.
Puizina-Ivić N; Sapunar D; Marasović D; Mirić L
Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009
[TBL] [Abstract][Full Text] [Related]
15. Increased level of c-erbB-2/neu/HER-2 protein in cutaneous squamous cell carcinoma.
Ahmed NU; Ueda M; Ichihashi M
Br J Dermatol; 1997 Jun; 136(6):908-12. PubMed ID: 9217824
[TBL] [Abstract][Full Text] [Related]
16. GLUT-1 Expression in Cutaneous Basal and Squamous Cell Carcinomas.
Abdou AG; Eldien MM; Elsakka D
Int J Surg Pathol; 2015 Sep; 23(6):447-53. PubMed ID: 26092229
[TBL] [Abstract][Full Text] [Related]
17. HIPK2 expression in progression of cutaneous epithelial neoplasm.
Kwon MJ; Min SK; Seo J; Kim DH; Sung CO; Lim MS; Cho J; Park HR
Int J Dermatol; 2015 Mar; 54(3):347-54. PubMed ID: 25711204
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical localization of a novel beta 1 integrin in normal and pathologic squamous epithelia.
Cerri A; Favre A; Giunta M; Corte G; Grossi CE; Berti E
J Invest Dermatol; 1994 Feb; 102(2):247-52. PubMed ID: 7508965
[TBL] [Abstract][Full Text] [Related]
19. Viral DNA detection and RAS mutations in actinic keratosis and nonmelanoma skin cancers.
Zaravinos A; Kanellou P; Spandidos DA
Br J Dermatol; 2010 Feb; 162(2):325-31. PubMed ID: 19849697
[TBL] [Abstract][Full Text] [Related]
20. Selective in situ protein expression profiles correlate with distinct phenotypes of basal cell carcinoma and squamous cell carcinoma of the skin.
Stelkovics E; Kiszner G; Meggyeshazi N; Korom I; Varga E; Nemeth I; Molnar J; Marczinovits I; Krenacs T
Histol Histopathol; 2013 Jul; 28(7):941-54. PubMed ID: 23446646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
